Skip to main content
Evotec SE (ETR:EVT)
Germany flag Germany · Delayed Price · Currency is EUR
5.08
-0.07 (-1.26%)
Apr 29, 2026, 11:19 AM CET

Evotec SE Revenue

In the year 2025, Evotec SE had annual revenue of 788.37M EUR, down -1.08%. Evotec SE had revenue of 253.27M in the quarter ending December 31, 2025, with 14.49% growth.

Revenue
788.37M
Revenue Growth
-1.08%
P/S Ratio
1.16
Revenue / Employee
176.49K
Employees
4,467
Market Cap
913.63M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025788.37M-8.59M-1.08%
Dec 31, 2024796.97M15.54M1.99%
Dec 31, 2023781.43M29.98M3.99%
Dec 31, 2022751.45M133.41M21.59%
Dec 31, 2021618.03M117.11M23.38%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Merck KGaA 21.10B
Siemens Healthineers AG 23.30B
Bayer Aktiengesellschaft 45.58B
Fresenius SE & Co. KGaA 22.87B
SCHOTT Pharma AG & Co. KGaA 995.03M
Dermapharm Holding SE 1.18B
Drägerwerk AG & Co. KGaA 3.48B
Redcare Pharmacy NV 2.94B
Revenue Rankings

Evotec SE News

More News